Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Juni 2026 07:00 ET | Quelle: Aclarion, Inc.

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
09. Juni 2026 07:00 ET | Quelle: Aclarion, Inc.

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
08. Juni 2026 07:05 ET | Quelle: Aclarion, Inc.

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal
08. Juni 2026 07:00 ET | Quelle: Aclarion, Inc.

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
01. Juni 2026 06:00 ET | Quelle: Aclarion, Inc.

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune Biomarker Study
28. Mai 2026 14:49 ET | Quelle: Aclarion, Inc.

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Aclarion Comments on Echo Lake Capital’s Letter and Unsolicited Proposal
07. Mai 2026 06:00 ET | Quelle: Aclarion, Inc.

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
06. Mai 2026 06:00 ET | Quelle: Aclarion, Inc.

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
30. April 2026 06:00 ET | Quelle: Aclarion, Inc.

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
28. April 2026 06:00 ET | Quelle: Aclarion, Inc.

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Nächste Seite